Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study

Background: Monoclonal antibody (mAb) therapy is a promising antiviral intervention for Coronovirus disease (COVID-19) with a potential for both treatment and prophylaxis. However, a major barrier to implementing mAb therapies in clinical practice is the intricate nature of mAb preparation and deliv...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Assem Ashimova, Askhat Myngbay, Sergey Yegorov, Baurzhan Negmetzhanov, Irina Kadyrova, Angelina Yershova, Ulpan Kart, Matthew S. Miller, Gonzalo Hortelano
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2022-09-01
Serie:	Pharmaceutics
Soggetti:	COVID-19 SARS-CoV-2 IgG monoclonal antibody CR3022 cell encapsulation
Accesso online:	https://www.mdpi.com/1999-4923/14/10/2042
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!